Local therapy is critical in localised pelvic rhabdomyosarcoma: Experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee

European Journal of Cancer

Volumn 48, Issue 13, 2012, Pages 2020-2027

  Réguerre, Yves ^a   Martelli, Hélne ^b   Rey, Annie ^c   Rogers, Timothy ^d   Gaze, Mark ^e   Arush, Myriam Weyl Ben ^f   Devalck, Christine ^g   Oberlin, Odile ^c   Stevens, Michael ^h   Orbach, Daniel ⁱ  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^f RAMBAM MEDICAL CENTER   (Israel)

^g HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

ⁱ INSTITUT CURIE   (France)

Author keywords

Chemotherapy; Children; Local treatment; Localised pelvic rhabdomyosarcoma; Radiotherapy; SIOP MMT; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PROGNOSIS; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CHILD; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INFANT; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PELVIC RHABDOMYOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 84865150757     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.11.011     Document Type: Article

References (24)

1. M.C. Stevens Treatment for childhood rhabdomyosarcoma: the cost of cure Lancet Oncol 6 2 2005 77 84 (Pubitemid 40197701)
2. R.B. Raney, J.R. Anderson, and F.G. Barr Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V J Pediatr Hematol Oncol 23 4 2001 215 220 (Pubitemid 32524925)
3. C.A. Stiller, M.C. Stevens, C. Magnani, and I. Corazziari Survival of children with soft-tissue sarcoma in Europe since 1978: results from the EUROCARE study Eur J Cancer 37 6 2001 767 774 (Pubitemid 32304413)
4. S.L. Wolden, J.R. Anderson, and W.M. Crist Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III J Clin Oncol 17 11 1999 3468 3475 (Pubitemid 29517917)
5. D. Orbach, A. Rey, and O. Oberlin Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee J Clin Oncol 23 19 2005 4363 4371 (Pubitemid 46207010)
6. F. Flamant, C. Rodary, P.A. Voute, and J. Otten Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results Radiother Oncol 3 3 1985 227 236 (Pubitemid 15112222)
7. F. Flamant, C. Rodary, and A. Rey Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84 Eur J Cancer 34 7 1998 1050 1062 (Pubitemid 28308346)
8. M.C. Stevens, A. Rey, and N. Bouvet Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence. third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89 J Clin Oncol 23 12 2005 2618 2628 (Pubitemid 46179450)
9. C. Rodary, F. Flamant, and S.S. Donaldson An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP) Med Pediatr Oncol 17 3 1989 210 215 (Pubitemid 19187089)
10. H.M. Maurer, M. Beltangady, and E.A. Gehan The Intergroup Rhabdomyosarcoma Study-I. A final report Cancer 61 2 1988 209 220 (Pubitemid 18056471)
11. W.A. Newton Jr., E.A. Gehan, and B.L. Webber Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - an Intergroup Rhabdomyosarcoma Study Cancer 76 6 1995 1073 1085
12. M. Stevens, A. Rey, and N. Bouvet SIOP MMT 95: Intensified (6 drug) versus standard (IVA) chemotherapy for high risk non metastatic rhabdomyosarcoma (RMS) J Clin Oncol Suppl. 15 2004 802s [abstr 8515]
13. A.B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler Reporting results of cancer treatment Cancer 47 1 1981 207 214 (Pubitemid 11167383)
14. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
15. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 3 1966 163 170
16. D. Cox Regression models and life-tables J R Stat Soc B 34 1972 187 220
17. M.L. Blakely, R.J. Andrassy, and R.B. Raney Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997 J Pediatr Surg 38 3 2003 347 353 (Pubitemid 36278691)
18. R.B. Raney, J.A. Stoner, and D.O. Walterhouse Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997 Pediatr Blood Cancer 42 7 2004 618 625 (Pubitemid 38669750)
19. G. Cecchetto, G. Bisogno, and J. Treuner Role of surgery for nonmetastatic abdominal rhabdomyosarcomas: a report from the Italian and German Soft Tissue Cooperative Groups Studies Cancer 97 8 2003 1974 1980 (Pubitemid 36397274)
20. J.L. Meza, J. Anderson, A.S. Pappo, and W.H. Meyer Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group J Clin Oncol 24 24 2006 3844 3851 (Pubitemid 46630730)
21. J. Godzinski, F. Flamant, A. Rey, M.T. Praquin, and H. Martelli Value of postchemotherapy bioptical verification of complete clinical remission in previously incompletely resected (stage I and II pT3) malignant mesenchymal tumors in children: International Society of Pediatric Oncology 1984 Malignant Mesenchymal Tumors Study Med Pediatr Oncol 22 1 1994 22 26 (Pubitemid 23361824)
22. S.L. Spunt, T.A. Sweeney, and M.M. Hudson Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors J Clin Oncol 23 28 2005 7143 7151
23. S.L. Wolden, T.H. La, and M.P. LaQuaglia Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma Cancer 97 1 2003 179 185 (Pubitemid 36033877)
24. H. Martelli, C. Haie-Meder, and S. Branchereau Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience J Pediatr Surg 44 1 2009 190 196